Skip to main content

letter

. 1995 May;71(835):318. doi: 10.1136/pgmj.71.835.318

Doxorubicin-induced cardiotoxicity.

PMCID: PMC2398096 PMID: 7596949

318

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Cummings J., Merry S., Willmott N. Disposition kinetics of adriamycin, adriamycinol and their 7-deoxyaglycones in AKR mice bearing a sub-cutaneously growing ridgway osteogenic sarcoma (ROS). Eur J Cancer Clin Oncol. 1986 Apr;22(4):451–460. doi: 10.1016/0277-5379(86)90112-4. [DOI] [PubMed] [Google Scholar]
Cummings J., Milstead R., Cunningham D., Kaye S. Marked inter-patient variation in adriamycin biotransformation to 7-deoxyaglycones: evidence from metabolites identified in serum. Eur J Cancer Clin Oncol. 1986 Aug;22(8):991–1001. doi: 10.1016/0277-5379(86)90067-2. [DOI] [PubMed] [Google Scholar]
Sriskandan S., O'Brien M. E., Smith I. E., Collins P., Gore M. E. Aggressive management of doxorubicin-induced cardiomyopathy associated with 'low' doses of doxorubicin. Postgrad Med J. 1994 Oct;70(828):759–761. doi: 10.1136/pgmj.70.828.759. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES